HOT TOPICS

MINING & RESOURCES

BIOTECH & PHARMA

Algernon Pharmaceuticals CSE AGN Ifenprodil study treatment idiopathic pulmonary fibrosis IPF chronic cough

Algernon Pharmaceuticals to present findings of Ifenprodil study for treatment of idiopathic pulmonary fibrosis

Clinical stage Canadian drug development company Algernon Pharmaceuticals (CSE: AGN) will present the results of a phase 2a study into NP-120 (Ifenprodil) for the treatment of idiopathic pulmonary fibrosis (IPF) and chronic ...

TECHNOLOGY

TraceSafe CSE TSF carbon management platform ShiftCarbon neutrality netzero

TraceSafe launches carbon management platform ShiftCarbon

TraceSafe (CSE: TSF) has announced the launch of its carbon management platform, ShiftCarbon, which aims to support organisations to fulfil carbon neutrality and netzero goals. ShiftCarbon is the company’s biggest launch ...

OIL, GAS & ENERGY

First Hydrogen TSX-V FHYD green hydrogen energy production North America

First Hydrogen announces green hydrogen production plans for North America

First Hydrogen (TSX-V: FHYD) is setting its sights on green hydrogen production within the North American market – revealing expansion plans for Canada and the US. The company recently commenced the development of four ke...

INDUSTRIALS & JUNIORS

UPCOMING IPOs

[vc_acf field_group=”75531″ field_from_75531=”field_60cc9cc16374d” align=”center”]